Marshall Wace’s Medline Inc MDLN Stock Holding History

Marshall Wace’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-641,715	Closed	-$28.6M	–	3890
2026 Q1	$28.6M	Buy	641,715 +496,228	+341%	+$21.9M	0.03%	569
2025 Q4	$6.11M	Buy	+145,487	New	+$6.14M	0.01%	1068

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Marshall Wace's MDLN Position: Q2 2026 in Review

Marshall Wace sold out of Medline Inc (MDLN) in Q2 2026, closing a stake of 641,715 shares — an estimated $28.6M sold.

Marshall Wace first reported a position in MDLN in Q4 2025 and held it in 2 quarters. The position peaked at $28.6M in Q1 2026. 409 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

Marshall Wace reported no remaining Medline Inc position as of Q2 2026 after selling out during the quarter.
Marshall Wace sold 641,715 Medline Inc shares in Q2 2026, an estimated $28.6M.
Marshall Wace first reported a position in Medline Inc in Q4 2025 and held it in 2 quarters.
Marshall Wace's Medline Inc position peaked at $28.6M in Q1 2026.
409 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.